PIK3CA and lung carcinoma: In addition, studies have reported that SLC34A2 may inhibit the growth, invasion, and migration of lung cancer cells through PI3K/Akt and Ras/Raf/MEK signaling pathways, by acting as a tumor suppressor (23, 24).